Medical Imaging in Bladder Tumors by MRI
- Conditions
- Bladder TumorMagnetic Resonance Imaging
- Registration Number
- NCT06033040
- Brief Summary
This study prospectively included 178 patients with bladder neoplastic lesions who planned to undergo surgery (with or without preoperative neoadjuvant chemotherapy). Inclusion criteria: Patients with pathologically confirmed bladder cancer after radical or partial cystectomy or TURBT (\< 2 weeks between surgical resection and imaging). Exclusion criteria: 1) Prior history of chemotherapy and/or radiotherapy; 2) No surgical resection; 3) The interval between surgical resection and imaging examination is \> 2 weeks; 4) Obvious artifacts; 5)MRI scan contraindications. All subjects underwent pelvic MRI. Data was collected using a Siemens VIDA 3TMR scanner (Siemens Healthcare, Erlangen, Germany). All subjects underwent standardized scanning protocols. The obtained images are post-processed and the experimental results are analyzed statistically.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 178
- Clinical diagnosis of bladder neoplasm
- Must undergo radical or partial cystectomy or TURBT surgery within 2 weeks between surgical resection and imaging
- A history of pelvic radiotherapy or chemotherapy;
- Lack of pathological findings or no surgery;
- The interval between surgical resection and imaging examination > 2 weeks;
- Poor image quality due to poor coordination or motion artifacts;
- MRI scan contraindications
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method quantitative parameters by MRI From the time the participants completed the MRI scan to the post-processing of the resulting images,assessed up to 2 months quantitative parameters by functional MRI
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Sun Yat-sen Memorial Hospital, Sun Yat-sen University
🇨🇳Guangzhou, Guang Dong, China